← All trials
NCT04704050
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- May 15, 2021
- Primary completion
- Dec 1, 2022
- Completion date
- Dec 1, 2022
- First posted
- Jan 11, 2021
- Last posted
- Jun 9, 2021
- Enrollment
- 330
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Tulane UniversityLead sponsor
- Tulane UniversityOverall official - principal investigator
- SanofiCollaborator
- University of WashingtonCollaborator
- Cardiac Designs Inc.Collaborator
- Marrek, INCCollaborator
- PreventiceCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.